Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M62,353Revenue $M100,887Net Margin (%)2.0Z-Score3.2
Enterprise Value $M74,099EPS $2.6Operating Margin %3.6F-Score8
P/E(ttm))32.3Cash Flow Per Share $3.6Pre-tax Margin (%)3.0Higher ROA y-yY
Price/Book3.110-y EBITDA Growth Rate %24.4Quick Ratio0.5Cash flow > EarningsY
Price/Sales0.75-y EBITDA Growth Rate %20.7Current Ratio0.6Lower Leverage y-yY
Price/Cash Flow14.9y-y EBITDA Growth Rate %5.0ROA % (ttm)3.7Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)9.6Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M727ROI % (ttm)3.5Gross Margin Increase y-yY

Gurus Latest Trades with ESRX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ESRXGlenn Greenberg 2014-12-31 Reduce-2.33%$69.65 - $85.96
($78.34)
$ 85.789%Reduce -17.94%4,088,652
ESRXChris Davis 2014-12-31 Add0.65%$69.65 - $85.96
($78.12)
$ 85.789%Add 22.09%13,002,699
ESRXWallace Weitz 2014-12-31 Reduce-0.19%$69.65 - $85.96
($78.12)
$ 85.789%Reduce -5.17%1,684,987
ESRXVanguard Health Care Fund 2014-12-31 Reduce-0.07%$69.65 - $85.96
($78.26)
$ 85.789%Reduce -11.45%3,206,500
ESRXDodge & Cox 2014-12-31 Add0.06%$69.65 - $85.96
($78.26)
$ 85.789%Add 4.22%19,248,979
ESRXHOTCHKIS & WILEY 2014-12-31 Reduce-0.05%$69.65 - $85.96
($78.26)
$ 85.789%Reduce -10.80%1,651,500
ESRXCharles Brandes 2014-12-31 Reduce-0.04%$69.65 - $85.96
($78.26)
$ 85.789%Reduce -2.05%2,207,728
ESRXMario Gabelli 2014-12-31 Reduce-0.04%$69.65 - $85.96
($78.12)
$ 85.789%Reduce -45.53%134,879
ESRXWarren Buffett 2014-12-31 Sold Out -0.03%$69.65 - $85.96
($78.34)
$ 85.789%Sold Out0
ESRXJoel Greenblatt 2014-12-31 Reduce-0.02%$69.65 - $85.96
($78.34)
$ 85.789%Reduce -46.28%25,788
ESRXKen Fisher 2014-12-31 Add$69.65 - $85.96
($78.26)
$ 85.789%Add 1.16%528,812
ESRXJohn Keeley 2014-12-31 Add$69.65 - $85.96
($78.26)
$ 85.789%Add 0.13%30,998
ESRXRuane Cunniff 2014-12-31 Reduce$69.65 - $85.96
($78.26)
$ 85.789%Reduce -8.69%4,905
ESRXGlenn Greenberg 2014-09-30 Add0.79%$65.6 - $75.51
($71.37)
$ 85.7817%Add 6.50%4,982,726
ESRXJoel Greenblatt 2014-09-30 Reduce-0.15%$65.6 - $75.51
($71.37)
$ 85.7817%Reduce -78.07%48,001
ESRXCharles Brandes 2014-09-30 Add0.14%$65.6 - $75.51
($71.37)
$ 85.7817%Add 7.22%2,253,914
ESRXWallace Weitz 2014-09-30 Add0.07%$65.6 - $75.51
($71.24)
$ 85.7817%Add 1.98%1,776,907
ESRXVanguard Health Care Fund 2014-09-30 Add0.06%$65.6 - $75.51
($71.24)
$ 85.7817%Add 10.91%3,621,200
ESRXDodge & Cox 2014-09-30 Add0.04%$65.6 - $75.51
($71.24)
$ 85.7817%Add 3.33%18,469,695
ESRXMario Gabelli 2014-09-30 Reduce-0.04%$65.6 - $75.51
($71.37)
$ 85.7817%Reduce -32.33%247,614
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ESRX is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


ESRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Stettin Glen D.Sr. VP, Clin. Res. & New Sol. 2015-03-02Sell2,674$84.394.4view
Stettin Glen D.Sr. VP, Clin. Res. & New Sol. 2015-02-25Sell27,603$87.550.63view
Ebling Keith J.Exec. VP and General Counsel 2014-12-02Sell10,000$84.254.57view
Miller Steven BSr. VP & Chief Med. Officer 2014-12-01Sell4,896$83.575.42view
Stettin Glen D.Sr. VP, Clin. Res. & New Sol. 2014-11-28Sell10,800$82.966.2view
MAC MAHON THOMAS PDirector 2014-11-21Sell12,694$80.938.86view
Stettin Glen D.Sr. VP, Clin. Res. & New Sol. 2014-11-21Sell10,874$81.58.1view
PARKER JOHN ODirector 2014-11-17Sell25,822$78.7511.87view
Breen Maura CDirector 2014-11-07Sell13,128$77.813.24view
IGNACZAK EDWARD BEVP 2014-09-05Sell9,886$75.2817.03view

Press Releases about ESRX :

    Quarterly/Annual Reports about ESRX:

    News about ESRX:

    Articles On GuruFocus.com
    Charles Brandes' Top Growth Stocks Apr 07 2015 
    CVS Health Corporation (CVS) Dividend Stock Analysis Apr 07 2015 
    UnitedHealth Group Is Ready For A Huge Pharmacy Deal Apr 06 2015 
    Gilead Experiencing Bumpy Ride Despite Strong Fundamentals Apr 03 2015 
    Vanguard Health Care Fund's Undervalued Stocks Apr 03 2015 
    UnitedHealth Planning Catamaran Corp’s Acquisition For $12.78 Billion Apr 02 2015 
    Why Express Scripts is a Good Buy at Current Levels Apr 01 2015 
    Aetna: Solid Prospects in a Volatile Environment Mar 31 2015 
    Analyzing Steven Romick's New Buys: Express Scripts (ESRX) Mar 19 2015 
    Rolfe Adds One Company to Portfolio in Fourth Quarter Feb 18 2015 


    More From Other Websites
    Will Walgreens make a run for Express Scripts? Apr 10 2015
    Express Scripts, Silicon Motion, Apogee Break Out Apr 09 2015
    Express Scripts climbs as Walgreens states interest in deals Apr 09 2015
    Express Scripts climbs as Walgreens states interest in deals Apr 09 2015
    Stocks Wobble At Starting Line; Express Scripts Up, Altera Dips Apr 09 2015
    Express Scripts Holding Company Announces First Quarter 2015 Earnings Conference Call Apr 08 2015
    Express Scripts Holding Company Announces First Quarter 2015 Earnings Conference Call Apr 08 2015
    After Rising 80%, UnitedHealth Looks Pricey Apr 03 2015
    The Zacks Analyst Blog Highlights: UnitedHealth Group, Catamaran, CVS Health, Express Scripts and... Apr 01 2015
    SIOR chapter announces deals of the year for western Pennsylvania Apr 01 2015
    Express Scripts (ESRX) Stock Is Up Today on Heavy Trading Volume Mar 31 2015
    Breakout time for Express Scripts? Mar 31 2015
    UnitedHealth Arm to Boost Pharmacy Benefits with Catamaran - Analyst Blog Mar 31 2015
    Post-UNH Deal, Spotlight on Pharmacy Benefit Stocks - Analyst Blog Mar 31 2015
    [$$] UnitedHealth to Buy Catamaran for $12.8 Billion in Cash Mar 30 2015
    Catamaran Corporation -- Moody's puts Catamaran's ratings on review for upgrade following news of... Mar 30 2015
    UnitedHealth Pays $12.8 Bil To Double Prescription Clients Mar 30 2015
    UnitedHealth Group Incorporated -- Moody's affirms UnitedHealth's ratings (sr. debt at A3) on... Mar 30 2015
    UnitedHealth bulks up for prescription drug cost battle Mar 30 2015
    Stocks End Higher on China Easing Hopes, M&A Activity Mar 30 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    Srichardson
    ReplySrichardson - 8 months ago
    How do you see the % of Total Asset for a position in a guru portfolio?
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK